Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9LY8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,467 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of SKYRIZI 180 MG/1.2 ML on-body injectors. This is a non-set-aside contract with a completion date of February 10, 2026, and performance will occur at the awardee's location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used to treat moderate-to-severe plaque psoriasis and other inflammatory conditions. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems including the Department of Defense and military treatment facilities.
This delivery order represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of prescription medications, specialty pharmaceuticals, vaccines, and medical supplies to support military healthcare programs worldwide. The competitively awarded delivery order structure allows the Defense Logistics Agency to procure critical pharmaceutical commodities efficiently through an established prime vendor relationship.
Quick answers
Who was awarded contract SPE2DR26F9LY8?
SPE2DR26F9LY8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F9LY8 worth?
The government has obligated $12,467 on SPE2DR26F9LY8.
Is contract SPE2DR26F9LY8 an order under another contract?
Yes. SPE2DR26F9LY8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LY8 competed?
The extent of competition for SPE2DR26F9LY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award